Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 
Articles » NINDS Inclusion Body Myositis Information Page: NINDS
 

NINDS Inclusion Body Myositis Information Page: NINDS

Article title: NINDS Inclusion Body Myositis Information Page: NINDS

Main condition: Inclusion Body Myositis

Conditions: Inclusion Body Myositis


What is Inclusion Body Myositis?
Inclusion body myositis (IBM) is an inflammatory muscle disease characterized by slow and relentlessly progressive muscle weakness and atrophy of the muscles. The disorder is very similar to another inflammatory myopathy called polymyositis. In fact, IBM is often diagnosed in cases of polymyositis that are unresponsive to therapy. However, IBM has its own distinctive features. The onset of muscle weakness in IBM is generally gradual (over months or years). Also, IBM, which occurs more frequently in men than women, affects both the proximal (closest to the center of the body) and distal (farthest from the center of the body) muscles. There may be weakness of the wrist and finger muscles and atrophy of the quadricep muscles in the legs. Atrophy or shrinking of the forearms is also characteristic. Difficulty swallowing (dysphagia) occurs in approximately half of IBM cases. Symptoms of the disease usually begin after the age of 50, although the disease can sometimes occur earlier. Falling and tripping are usually the first noticeable symptoms of IBM. For some patients the disorder begins with weakness in the hands causing difficulty with gripping, pinching, and buttoning.

Is there any treatment?
There is no standard course of treatment for IBM. The disease is unresponsive to corticosteroids and other immunosuppressive drugs. Some evidence suggests that intravenous immunoglobulin may have a slight, but transient, beneficial effect in a small number of cases. Physical therapy may be helpful in maintaining mobility. Other therapy is symptomatic and supportive.

What is the prognosis?
IBM is generally resistant to all therapies, and its rate of progression also appears to be unaffected by the present treatments.

What research is being done?
The NINDS conducts and supports a vigorous program of research aimed at discovering new ways to diagnose, treat, and, ultimately, cure neuromuscular disorders including inflammatory myopathies such as IBM.

 Organizations

American Autoimmune Related Diseases Association
22100 Gratiot Avenue
Eastpointe
East Detroit, MI 48201-2227
aarda@aol.com
https://www.aarda.org/
Tel: 586-776-3900 800-598-4668
Fax: 586-776-3903

Myositis Association of America
755 Cantrell Avenue
Suite C
Harrisonburg, VA 22801
maa@myositis.org
https://www.myositis.org/
Tel: 540-433-7686
Fax: 540-432-0206

Muscular Dystrophy Association
3300 East Sunrise Drive
Tucson, AZ 85718-3208
mda@mdausa.org
https://www.mdausa.org/
Tel: 520-529-2000 800-572-1717
Fax: 520-529-5300

Related NINDS Publications and Information

  • NIH Myositis Outcomes Workshop
    Health Disparities Working Group Meeting: Cognitive and Emotional Health Myositis Outcomes Workshop

    This fact sheet is in the public domain. You may copy it.Provided by:
    The National Institute of Neurological Disorders and Stroke
    National Institutes of Health
    Bethesda, MD 20892


  •  

    By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

    Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise